Harbor UCLA Medical Center
Torrance, California, 90509, United States
NCT Number: NCT07353944
The goal of this clinical trial is to study whether transcutaneous tibial nerve stimulation (TTNS) is a feasible and satisfactory treatment for overactive bladder in Urogynecology patients who receive their care at a county hospital.
Researchers will compare outcomes with TTNS to patients who undergo percutaneous tibial nerve stimulation (PTNS).
The main questions it aims to answer are:
* Is TTNS non-inferior to PTNS in terms of OAB symptom severity? * Are patients as satisfied with TTNS as they are with PTNS? * Are patients' symptoms improved with TTNS?
Participants will:
* either undergo PTNS or be taught how to do TTNS therapy at home * complete surveys about their bladder symptoms and satisfaction with treatment
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Torrance, California, 90509, United States
Patients who consent to this study will be randomly assigned to either receive PTNS in clinic weekly, or TTNS every other day at home. The severity of their overactive bladder symptoms and satisfaction with treatment will be assessed before starting treatment as well as 6 weeks, 12 weeks and 6 months after starting treatment. The results of these surveys will be compared between groups to determine whether TTNS is non-inferior to PTNS in this particular patient population.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
neuromodulation therapy for overactive bladder that targets the posterior tibial nerve
Other names: PTNS, TTNS
Time frame: Baseline, 6 weeks, 12 weeks, 6 months post treatment initiation
OAB symptom severity
Time frame: 6 weeks, 12 weeks, 6 months post treatment initiation
Patient satisfaction with the intervention (Y/N; would you recommend it to others?)
Time frame: 6 weeks, 12 weeks, 6 months post treatment initiation
Patient global assessment of overall improvement, graded on a scale of 1-7
Time frame: 6 months post treatment initiation
Number and percentage of PTNS visits (PTNS arm); Patient reported number of self-administered TTNS treatments per week
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Other
Assessment of Patient Satisfaction With Transcutaneous Tibial Nerve Stimulation in a County Hospital System
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05799313
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cleveland, Ohio, United States
View Trial DetailsNCT05557279
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Maywood, Illinois, United States
View Trial DetailsNCT06198439
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Houston, Texas, United States
View Trial DetailsNCT06206512
Cardiovascular Diseases, Female Urogenital Diseases
Dallas, Texas, United States
View Trial Details